AcquiSci is a development stage company whose medical device-based technology platform includes therapeutic anti-inflammatory applications for diseases such as ischemic stroke and chronic heart failure as well as a process for purifying biofluids.
A technology play with a near term, high value medical exit in a $3.5B market. We plan to sell or exclusively license ProACTive to an existing radiation therapy technology company based on their gaining a competitive advantage and increased market share by being the first to offer adaptive planning capability.
Develops technology for augmenting the potency of vaccines.
Portable endoscopic capture
Embera is a specialty pharmaceutical company developing a proprietary drug combination, EMB-001, to treat a broad range of addictions and obesity. Priority development programs are smoking cessation and cocaine dependence.
ITI is developing novel nucleic acid vaccines utilizing our patented LAMP Technology. Our primary area of focus is rapidly growing allergy market.
INDIGO's mission is to provide drug developers,toxicologists and researchers with cost-effective, reliable and user-friendly target-specific nuclear receptor assay products and services.
JDP Therapeutics Inc., is a specialty pharmaceutical company focused on developing small molecule therapeutics to treat life threatening diseases with significant unmet medical needs.
Makefield Therapeutics is a drug development company focused on advancing its first two product candidates into the clinic with early demonstration of therapeutic activity.
Probity Medical Transcription is committed to providing medical transcription and document management services at the highest professional and technologically advanced level, and to support that goal by providing premium, uncompromised client service.
SAJE Pharma, an emerging biopharmaceutical company, is focused on developing new drugs for unmet medical needs. We have an option to license compounds that target the nitric oxide signaling system. Our lead compound will be developed to treat asthma.
SkillSurvey is a SAAS company selling to human resource leaders at healthcare and pharma orgs, as well as F1000 and SMB companies.
Sword Diagnostics is introducing a revolutionary new detection system that improves the ability to detect low concentrations of disease biomarkers.
3ED is developing a non-invasive intracranial pressure (ICP) monitor that gathers information from the blood vessels in the back of a patient's eye. It will be sold to healthcare facilities along with a single use disposable that touches the eye.
